Systematic molecular characterization of human induced pluripotent stem cell (iPSC) lines carrying disease-associated mutations is needed to distinguish disease-related biology from variation in cell state, genomic integrity, and genome-editing history, yet such systematic characterization is uncommon. Here, we profile...
Le Qi, T. Bertucci, Susan Borden et al.· Neuron· 0 citations
Using isogenic human induced pluripotent stem cell-derived microglia carrying the pathogenic MAPT IVS10+16 mutation, tau is identified as a regulator of microglial lysosomal function and degradative capacity is identified as a modifiable component of the microglial response to tau pathology.
Kylie J. Schache, Rui Zhang, Audrey Street et al.· bioRxiv· 0 citations
Iterative Mapping of proteoforms provides insights into proteoform complexity at the single-molecule level, with implications for understanding protein regulation in neurodegenerative diseases and beyond.
James Joly, V. Budamagunta, Zheng-Jian Zhang et al.· Nature Methods· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.